Evidence map›Paper›PMID 33300424›Full record

ArticleJDR clinical and translational research2022

Amalgam Phase-Down Part 2: UK-Based Knowledge, Opinions, and Confidence in the Alternatives.

O Bailey, C R Vernazza, S Stone, L Ternent, A-G Roche, C Lynch

Abstract read
In one paragraph

Article in JDR clinical and translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Model-Based Cost-Effectiveness of Direct Restorations: Amalgam Dominates.Community dentistry and oral epidemiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Developments in resin-based composites.British dental journal · 2022
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

O BaileySchool of Dental Sciences, Newcastle University, Newcastle upon Tyne, UK.
C R VernazzaSchool of Dental Sciences, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-6927-2974
S StoneSchool of Dental Sciences, Newcastle University, Newcastle upon Tyne, UK.
L TernentPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
A-G RocheBritish Dental Association, London, UK.
C LynchUniversity Dental School & Hospital, University College Cork, Cork, Ireland.

Funding

Department of Health CS-2014-14-011
6 · The paper itself

Abstract

introductionAmalgam use has recently been phased down, and the potential for a phase-out is being investigated.

objectivesThe study aimed to identify knowledge of the phase-down and opinions of a potential phase-out of amalgam by UK primary care clinicians and assess their confidence in using different materials in different situations.

methodsAn anonymized, prepiloted cross-sectional e-survey was used to assess primary care clinicians' knowledge and opinions of the amalgam phase-down and potential phase-out and their confidence in using amalgam and the alternatives in different situations. In total, 11,902 invitations were distributed through British dentist and therapist associations. Prior hypotheses were tested alongside descriptive statistics.

resultsResponse rate was 13% (

conclusionPrimary care clinicians have major personal and patient-centered concerns regarding the amalgam phase-down (of which they have limited knowledge) and potential phase-out. Many lack confidence in using the alternative, composite, to restore posterior teeth in difficult situations, whereas confidence in using amalgam in similar situations is high. Effective education of clinicians and understanding patients' needs, alongside policy changes, are required to enable a successful amalgam phase-down and potential phase-out. KNOWLEDGE TRANSFER STATEMENT: This study shows that UK primary care clinicians are worried about the phase-down of amalgam for themselves and their patients. Many lack confidence in the alternative, composite, when used in difficult situations, which is in stark contrast to amalgam. Knowledge of the phase-down is limited. There is a need for more effective education of clinicians, an understanding of patients' values, and policy changes to ensure the success of the phase-down and potential phase-out of amalgam.

Indexed as

Composite ResinsDental AmalgamCross-Sectional StudiesHumansUnited KingdomComposite ResinsDental Amalgamcaries treatmentclinical outcomescomposite materialshealth services researchrestorative dentistryrestorative materials

Identifiers

PMID33300424
PMCPMC8674793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.